Page last updated: 2024-11-07

fk 156

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

FK 156: structure given in first source; RN given refers to ((L)(R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122001
MeSH IDM0105876

Synonyms (9)

Synonym
d-lactyl-l-alanyl-alpha-glutamyl-(l)-meso-diaminopimelyl-(l)-glycine
glycine, n-(2-hydroxy-1-oxopropyl)-l-alanyl-d-gamma-glutamyl-l-erythro-alpha,epsilon-diaminopimelyl-, (r)-
fk 156
glycine, n-(2-hydroxy-1-oxopropyl)-l-alanyl-d-gamma-glutamyl-meso-alpha,epsilon-diaminopimelyl-, (r)-
(2r,6r)-2-amino-6-[[4-carboxy-4-[[(2s)-2-[[(2r)-2-hydroxypropanoyl]amino]propanoyl]amino]butanoyl]amino]-7-(carboxymethylamino)-7-oxo-heptanoic acid
A809673
DTXSID60997866
2-amino-6-{[4-carboxy-4-({2-[(1,2-dihydroxypropylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxybutylidene]amino}-7-[(carboxymethyl)imino]-7-hydroxyheptanoic acid
(2r,6r)-2-amino-6-[[4-carboxy-4-[[(2s)-2-[[(2r)-2-hydroxypropanoyl]amino]propanoyl]amino]butanoyl]amino]-7-(carboxymethylamino)-7-oxoheptanoic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The killing ability of macrophages and polymorphonuclear leukocytes of the immunosuppressed mice was also markedly enhanced by dosing with FK-156."( Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Watanabe, Y; Yokota, Y, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (67.86)18.7374
1990's2 (7.14)18.2507
2000's2 (7.14)29.6817
2010's5 (17.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.42 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (16.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]